Des dents blanches des années 1950 aux ratiches pourries par l’acide et le manque d’hygiène des seventies, jusqu’aux aux ...

Professionnels et patients de psychiatrie ont créé un groupe de rock au sein duquel ils partagent tout : répétitions, ...

Tomorrow Never Knows started a new, sophisticated era for The Beatles, paving the way for the psychedelic Sgt. Pepper's ...

In 1943, biochemist Albert Hoffman accidentally ingested a chemical that he had synthesized from a fungus and discovered that it created hallucinations. The mind-bending chemical was lysergic acid ...

Au CHRD, « La guerre en jeux » invite à redécouvrir l enfance pendant la guerre Par le prisme du jeu et du jouet, le CHRD propose une exposition au regard sensible et inédit sur l’endoctrinement, ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

A recent study by MindMed reveals that LSD could be a potential treatment for anxiety. A single dose significantly reduced anxiety symptoms in individuals with generalized anxiety disorder, with ...

The study enrolled 198 adults with anxiety at 22 sites across the U.S. Once a symbol of 1960s counterculture, the drug lysergic acid diethylamide, commonly known as LSD, is emerging from research labs ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...

The Studio LSD IPO witnessed a fairly strong response from investors, closing with an overall subscription of 3.23 times. The issue received 4.21 crore bids against 1.30 crore shares on offer.